1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Cardiometabolic Drug News MARCH 2015

Cardiometabolic Drug News MARCH 2015

  • March 2015
  • -
  • Espicom Business Intelligence
  • -
  • 15 pages

Industry Trend Analysis - Sanofi's Lantus Successor Will See EC Approval And US Launch In Q215
Industry Brief - Amarin/Eddingpharm Enter Agreement For Vascepa In China
Industry Brief - Islet/BHV Enter Exclusive Licence Agreement For Phase II SGLT2 Inhibitor
Industry Brief - Laguna Completes Series B Financing; Appoints CEO
Industry Brief - Dance Biopharm Completes Private Financing
Industry Brief - Armetheon Raises Funds To Advance Tecarfarin Development In US
Industry Brief - AstraZeneca Gains Planning Consent For Global R&D Centre/Corporate HQ In Cambridge
Industry Brief - Savaysa Available In US Pharmacies
Industry Brief - Novartis' LCZ696 Gains FDA Priority Review For HFrEF
Industry Brief - Sandoz Launches Telmisartan In US
Industry Brief - Health Canada Approves Saxenda For Chronic Weight Management
Industry Brief - Glenmark Launches Trandolapril+Verapamil In US
Industry Brief - Actelion's NDA For Uptravi Accepted By FDA With Standard Review Time
Industry Brief - Eisai Meets Paediatric Needs With Tambocor Fine Granule Formulation
Industry Brief - Bayer's Adempas Approved In Japan For PAH
Industry Brief - BI Submits Idarucizumab BLA As Specific Reversal Agent For Pradaxa
Industry Brief - BI Submits Idarucizumab Applications In US/EU/Canada
Industry Trend Analysis - Controversial Data Suggest Advantage For Contrave In Obesity Market
Industry Trend Analysis - J&J Guiding Drug Development With New Research Platforms
Industry Brief - Lilly Accepts Recommendation To Extend Evacetrapib Phase III Trial
Industry Brief - Novo Nordisk Reports Positive Phase II Results With Oral Semaglutide For Type II Diabetes
Industry Brief - Lilly Delays Regulatory Submission Of Basal Insulin Peglispro
Industry Brief - Mast Initiates Phase IIa Studies Of AIR001 In HFpEF
Industry Brief - Melior Initiates Phase II Study With MLR-1023 For Type II Diabetes
Industry Brief - ARCA Granted US Patent Covering Gencaro
Industry Brief - La Jolla/FDA Reach SPA Agreement On LJPC-501 Phase III Trial In CRH
Industry Brief - MBT Receives US Patent NoA Covering Glyceollin For Diabetes/Obesity
Industry Brief - Positive Results From Adocia's HinsBet Fast Acting Insulin Formulation In Phase IIa Trial

Table Of Contents

Cardiometabolic Drug News MARCH 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

  • $ 75000
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both ...

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.